Presentations to Emergency Departments for COPD: A Time Series Analysis.

Publication Year: 2016

DOI:
10.1155/2016/1382434

PMCID:
PMC4904522

PMID:
27445514

Journal Information

Full Title: Can Respir J

Abbreviation: Can Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure This study is based in part on data provided by Alberta Health. The interpretation and conclusions contained herein are those of the researchers and do not necessarily represent the views of the Government of Alberta. Neither the government nor Alberta Health expresses any opinion in relation to this study. This study has not received funding. Sponsors have not had any role in the study. Dr. Rosychuk had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Competing Interests Dr. Rosychuk is salary-supported by Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada; formerly the Alberta Heritage Foundation for Medical Research) as a Health Scholar. Dr. Rowe's research is supported by a Tier 1 Canada Research Chair in Evidence-Based Emergency Medicine (Canadian Institutes of Health Research, Ottawa, Canada). In the past 3 years, Dr. Rowe has been involved in primary research funded by Merck, CEMPRA, and GlaxoSmithKline (GSK). He is not a member of any speaker's bureau or a paid consultant for any of these partners. The other authors declare no competing interests."

Evidence found in paper:

"Competing Interests: Dr. Rosychuk is salary-supported by Alberta Innovates-Health Solutions (AI-HS, Edmonton, Canada; formerly the Alberta Heritage Foundation for Medical Research) as a Health Scholar. Dr. Rowe's research is supported by a Tier 1 Canada Research Chair in Evidence-Based Emergency Medicine (Canadian Institutes of Health Research, Ottawa, Canada). In the past 3 years, Dr. Rowe has been involved in primary research funded by Merck, CEMPRA, and GlaxoSmithKline (GSK). He is not a member of any speaker's bureau or a paid consultant for any of these partners. The other authors declare no competing interests."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025